Mitochondria are increasingly recognized as central integrators of cellular metabolic states and immune signaling networks. The recent identification of Mitoxyperilysis, a mitochondria-driven lytic cell death pathway characterized by spatially confined oxidative membrane damage, challenges traditional notions of regulated necrosis. Here, we aim to reframe Mitoxyperilysis not merely as a death modality, but as a spatially encoded immunoregulatory program, linking mitochondrial dynamics to immune modulation and inflammatory microenvironments.

We synthesized emerging mechanistic and immunological evidence, drawing from live-cell imaging, biochemical analyses, and studies of macrophage and dendritic cell activation. Emphasis was placed on how mitochondrial positioning orchestrates localized reactive oxygen species (ROS) delivery, and how these subcellular dynamics translate into discrete membrane damage and focal release of damage-associated molecular patterns (DAMPs). We further integrated insights from models of chronic inflammation and autoimmunity, including rheumatoid arthritis and systemic lupus erythematosus, to map the functional consequences of spatially restricted mitochondrial signaling.

Mitoxyperilysis diverges from canonical lytic pathways, which rely on pore-forming proteins or global membrane rupture, by converting mitochondrial localization into a precisely tuned spatial amplifier of immune signaling. Localized ROS generation produces discrete sites of membrane perturbation and controlled DAMP release, establishing inflammatory niches that selectively shape macrophage polarization, dendritic cell maturation, and downstream adaptive immune responses. Dysregulation of this spatial program may drive persistent local inflammation, contributing to autoimmunity. By conceptualizing Mitoxyperilysis as a spatially organized immunomodulatory axis, we highlight how mitochondrial stress can generate microenvironment-specific inflammatory signaling, providing mechanistic insight into how subcellular organization governs immune outcomes.

Reframing Mitoxyperilysis as a bridge between mitochondrial dynamics and immune regulation emphasizes the importance of spatial control in inflammatory cell death. Unresolved questions include its stimulus specificity, physiological relevance, and therapeutic tractability. Future studies that interrogate the spatiotemporal orchestration of mitochondrial ROS and DAMP release could uncover novel strategies for modulating immune responses in chronic inflammatory and autoimmune diseases. Ultimately, Mitoxyperilysis represents a conceptual axis connecting subcellular architecture, redox signaling, and immune modulation, advancing our understanding of how mitochondria orchestrate localized, adaptive, and pathological immune responses.